Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ion Cristian Iaciu"'
Autor:
Elena-Monica BOGHICI, Andreea-Ioana PAROSANU, Ion Cristian IACIU, Mihaela OLARU, Cristina-Florina PIRLOG, Cristina ORLOV-SLAVU, Ana-Maria POPA, Cornelia NITIPIR
Publikováno v:
Modern Medicine, Vol 30, Iss 2, Pp 157-160 (2023)
Breast cancer is one of the most common malignancies, with a 10-year survival rate for early non-metastatic stages of over 80%. However, recurrence or relapse may occur decades after completing therapy, and cancer survivors have also a risk of second
Externí odkaz:
https://doaj.org/article/bff78c217fd9459b87c40618a9f63405
Autor:
Ioana-Miruna Stanciu, Cristina Florina Pirlog, Andrei-Wilhelm Anghel, Andreea Ioana Parosanu, Cristina Mihaela Olaru, Cristina Orlov-Slavu, Ion Cristian Iaciu, Ana Maria Popa, Radu Constantin Vrabie, Cornelia Nitipir
Publikováno v:
Medicina, Vol 59, Iss 4, p 696 (2023)
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors and endocrine therapy are the gold standards for systemic therapy for patients with hormone-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer. Followi
Externí odkaz:
https://doaj.org/article/3937aff8b0fd4bc7a9b4c3be4d446f1b
Autor:
Ioana-Miruna Stanciu, Andreea Ioana Parosanu, Cristina Orlov-Slavu, Ion Cristian Iaciu, Ana Maria Popa, Cristina Mihaela Olaru, Cristina Florina Pirlog, Radu Constantin Vrabie, Cornelia Nitipir
Publikováno v:
Diagnostics, Vol 13, Iss 5, p 987 (2023)
The latest and newest discoveries for advanced and metastatic hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer are the three cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) in associati
Externí odkaz:
https://doaj.org/article/6c9da4fa657d4d3eb1982d2cad5f926e
Autor:
Cornelia Niţipir, Andreea Parosanu, Ana-Maria Popa, Cătălina Lăcustoiu, Loredana Mitran, Ion Cristian Iaciu, Anca Pîslariu, Radu Vrabie, Cristina Orlov Slavu
Publikováno v:
ORL.ro. 2:25